Canada Committee Reviews Draft Of Landmark Generics Bill
The amendments to the Patent Act and the Food and Drug Act, if passed, would make Canada the first country to act on a World Trade Organization agreement in August for developed nations to allow generics to be sold cheaply to many countries in Africa and Asia.
The WTO's decision aimed to lay to rest a controversy...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login